EUCR

Eucrates Biomedical Acquisition Corp. Ordinary Shares

Delisted

EUCR was delisted on the 26th of April, 2023.

21 hedge funds and large institutions have $41.8M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+16
Holders Change %
+320%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
1
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
BlackRock
1
BlackRock
New York
$9.23M +$9.23M +925,000 New
6CM
2
683 Capital Management
New York
$5.99M +$5.99M +600,000 New
SC
3
Shay Capital
New York
$4.5M +$4.5M +450,763 New
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$3.92M -$34.8K -3,519 -0.9%
CH
5
CVI Holdings
Delaware
$3.51M +$3.51M +355,000 New
SFM
6
Sphera Funds Management
Israel
$3.01M +$3.01M +304,025 New
GPCM
7
Granite Point Capital Management
Massachusetts
$2M -$1.82M -182,693 -48%
EC
8
EcoR1 Capital
California
$2M +$2M +200,000 New
CC
9
Centiva Capital
New York
$1.04M +$1.04M +104,707 New
RCM
10
Radcliffe Capital Management
Pennsylvania
$998K
SCM
11
Suvretta Capital Management
New York
$998K
RCM
12
Rivernorth Capital Management
Florida
$998K +$998K +99,996 New
Jane Street
13
Jane Street
New York
$834K +$834K +83,552 New
AA
14
AQR Arbitrage
Connecticut
$756K +$756K +76,424 New
CAC
15
Cowen and Company
New York
$652K +$652K +65,296 New
WAM
16
Wolverine Asset Management
Illinois
$571K +$541K +54,228 +1,808%
CIM
17
Cowen Investment Management
New York
$499K +$499K +50,000 New
AC
18
Athanor Capital
New York
$127K +$127K +12,805 New
EAM
19
Exos Asset Management
New York
$104K +$104K +10,485 New
UBS Group
20
UBS Group
Switzerland
$39K +$39K +3,954 New